Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients

Epidemiology and Infection

Volumn 140, Issue 10, 2012, Pages 1848-1852

  Vehreschild, J J ^a   Brockelmann P J ^a   Bangard, C ^a   Verheyen, J ^a   Vehreschild, M J G T ^a   Michels, G ^a   Wisplinghoff, H ^b   Cornely, O A ^a,b,c  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c University of Cologne   (Germany)

Author keywords

Aspergillosis; influenza; leukaemia; neutropenia; posaconazole

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; GALACTOMANNAN; IFOSFAMIDE; MITOXANTRONE; OSELTAMIVIR; POSACONAZOLE; VORICONAZOLE;

2009 H1N1 INFLUENZA; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANGIOSARCOMA; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; FUNGUS SPORE; HIGH RISK PATIENT; HUMAN; INCIDENCE; LARGE CELL LYMPHOMA; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTIPLE MYELOMA; NEUTROPHIL COUNT; NOSE SMEAR; PHYSICAL DISEASE BY BODY FUNCTION; POLYMERASE CHAIN REACTION; REMISSION; RISK FACTOR;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COHORT STUDIES; FEMALE; FEVER OF UNKNOWN ORIGIN; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84865469532     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811002603     Document Type: Article

References (11)

1. Bautista E, et al. Clinical aspects of pandemic 2009 influenza A(H1N1) virus infection. New England Journal of Medicine 2010; 362: 1708-1719.
2. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infectious Diseases 2009; 9: 493-504.
3. Kumar D, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infectious Diseases 2010; 10: 521-526.
4. Lat A, et al. Invasive aspergillosis after pandemic (H1N1) 2009. Emerging Infectious Diseases 2010; 16: 971-973.
5. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998; 114: 629-634. (Pubitemid 28387551)
6. De Pauw B, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases 2008; 46: 1813-1821.
7. Cornely OA, et al. Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica 2009; 94: 113-122.
8. Vehreschild JJ, et al. Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort. Journal of Antimicrobial Chemotherapy 2010; 65: 1466-1471.
9. Greenberg SB. Viral pneumonia. Infectious Disease Clinics of North America 1991; 5: 603-621.
10. Fischer JJ, Walker DH. Invasive pulmonary aspergillosis associated with influenza. Journal of the American Medical Association 1979; 241: 1493-1494. (Pubitemid 9228496)
11. Lewis M, et al. Invasive pulmonary aspergillosis complicating influenza A pneumonia in a previously healthy patient. Chest 1985; 87: 691-693. (Pubitemid 15092132)